Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to depomedrol for radicular pain during lumbar foraminal block
IRCT20230702058645N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in radicular pain comparing Control: Depo-Medrol with Case: Dexmedetomidine + Depo-Medrol (2 arms). Primary endpoints: Pain severity, Disability severity and 1 more. Started Feb 2025; status: completed.
02
Drugs
dexmedetomidinemethylprednisolone
03
Conditions
radicular pain
Beyond the preview
Go deeper on IRCT20230702058645N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230702058645N1.